Globus Medical (GMED) fundamentals: P/E, valuation, undervalued?
Globus Medical · Health Care · ref. ETF XLV · price $82.54
In short — Globus Medical trades at 21.1× earnings (P/E), 15.3× forward, with a net margin of 17.0 % and revenue growth of +6 %. Read: Average P/E (P/E 21 (near the ~20-25 average)).
Is Globus Medical stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$82.54+35.0% over range
Aug 28, 25low $55.1 · high $96.82Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
Valuation : Average P/E — P/E 21 (near the ~20-25 average)
Valuation
21.1
P/E (price/earnings)
15.3
Forward P/E
—
PEG
2.4
Price/book (P/B)
$11.1B
Market cap
3.91
EPS
Profitability & growth
17.0 %
Net margin
+6 %
Revenue growth
-26 %
Earnings growth
$112M
Total debt
Globus Medical income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $1.0B | $190M | 18.6 % |
| 2023 | $1.6B | $123M | 7.8 % |
| 2024 | $2.5B | $103M | 4.1 % |
| 2025 | $2.9B | $538M | 18.3 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Globus Medical's P/E and is the stock undervalued? What's a good P/E?
Globus Medical's P/E is 21.1 (forward 15.3). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Average P/E".
Is Globus Medical profitable?
Globus Medical has a net margin of 17.0 % (EPS 3.91). The company is profitable.
Is GMED stock expensive?
Our read: "Average P/E" — P/E 21 (near the ~20-25 average). Cross-check with growth and sector.
💬 A question about Globus Medical? The JPI assistant answers using our backtest data.
Keep exploring Globus Medical